Skip to content
1887

Abstract

Mycobacteriophage D29 infects species belonging to the genus Mycobacterium including the deadly pathogen Mycobacterium tuberculosis. D29 is a lytic phage, although, related to the lysogenic mycobacteriophage L5. This phage is unable to lysogenize in mycobacteria as it lacks the gene encoding the phage repressor. Infection by many mycobacteriophages cause various changes in the host that ultimately leads to inactivation of the latter. One of the host targets often modified in the process is RNA polymerase. During our investigations with phage D29 infected (Msm) we observed that the promoters from both phage, and to a lesser extent those of the host were found to be more active in cells that were exposed to D29, as compared to the unexposed. Further experiments indicate that the RNA polymerase purified from phage infected cells possessed higher affinity for promoters particularly those that were phage derived. Comparison of the purified RNA polymerase preparations from infected and uninfected cells showed that several ancillary transcription factors, Sigma factor F, Sigma factor H, CarD and RbpA are prominently associated with the RNA polymerase from infected cells. Based on our observations we conclude that the higher activity of RNA polymerase observed in D29 infected cells is due to its increased association with ancillary transcription factors.

Funding
This study was supported by the:
  • Department of Science and Technology, Ministry of Science and Technology (Award SR/WosA/LS 68/2018G)
    • Principle Award Recipient: SHREYASENGUPTA
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001158
2022-03-30
2025-01-25
Loading full text...

Full text loading...

/deliver/fulltext/micro/168/3/mic001158.html?itemId=/content/journal/micro/10.1099/mic.0.001158&mimeType=html&fmt=ahah

References

  1. Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016; 13:e1002152 [View Article] [PubMed]
    [Google Scholar]
  2. Alexander PE, De P. The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada. Can J Infect Dis Med Microbiol 2007; 18:289–291 [View Article] [PubMed]
    [Google Scholar]
  3. Vergne I, Chua J, Singh SB, Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu Rev Cell Dev Biol 2004; 20:367–394 [View Article] [PubMed]
    [Google Scholar]
  4. Gross CA, Chan C, Dombroski A, Gruber T, Sharp M et al. The functional and regulatory roles of sigma factors in transcription. Cold Spring Harb Symp Quant Biol 1998; 63:141–155 [View Article] [PubMed]
    [Google Scholar]
  5. Gruber TM, Gross CA. Multiple sigma subunits and the partitioning of bacterial transcription space. Annu Rev Microbiol 2003; 57:441–466 [View Article] [PubMed]
    [Google Scholar]
  6. Waagmeester A, Thompson J, Reyrat JM. Identifying sigma factors in Mycobacterium smegmatis by comparative genomic analysis. Trends Microbiol 2005; 13:505–509 [View Article] [PubMed]
    [Google Scholar]
  7. Manganelli R, Provvedi R, Rodrigue S, Beaucher J, Gaudreau L et al. Sigma factors and global gene regulation in Mycobacterium tuberculosis. J Bacteriol 2004; 186:895–902 [View Article] [PubMed]
    [Google Scholar]
  8. Rodrigue S, Provvedi R, Jacques PE, Gaudreau L, Manganelli R. The sigma factors of Mycobacterium tuberculosis. FEMS Microbiol Rev 2006; 30:926–941 [View Article] [PubMed]
    [Google Scholar]
  9. Gomez M, Doukhan L, Nair G, Smith I. sigA is an essential gene in Mycobacterium smegmatis. Mol Microbiol 1998; 29:617–628 [View Article] [PubMed]
    [Google Scholar]
  10. Volpe E, Cappelli G, Grassi M, Martino A, Serafino A et al. Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology 2006; 118:449–460 [View Article] [PubMed]
    [Google Scholar]
  11. Manganelli R, Dubnau E, Tyagi S, Kramer FR, Smith I. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol 1999; 31:715–724 [View Article] [PubMed]
    [Google Scholar]
  12. Manganelli R, Hatfull GF. Sigma factors: key molecules in Mycobacterium tuberculosis physiology and virulence. Microbiol Spectr 2014; 2:MGM2–0007 [View Article]
    [Google Scholar]
  13. Collins DM, Kawakami RP, de Lisle GW, Pascopella L, Bloom BR et al. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 1995; 92:8036–8040 [View Article] [PubMed]
    [Google Scholar]
  14. Missiakas D, Raina S. The extracytoplasmic function sigma factors: role and regulation. Mol Microbiol 1998; 28:1059–1066 [View Article] [PubMed]
    [Google Scholar]
  15. Calamita H, Ko C, Tyagi S, Yoshimatsu T, Morrison NE et al. The Mycobacterium tuberculosis SigD sigma factor controls the expression of ribosome-associated gene products in stationary phase and is required for full virulence. Cell Microbiol 2005; 7:233–244 [View Article] [PubMed]
    [Google Scholar]
  16. Sun R, Converse PJ, Ko C, Tyagi S, Morrison NE et al. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set. Mol Microbiol 2004; 52:25–38 [View Article] [PubMed]
    [Google Scholar]
  17. Rammohan J, Ruiz Manzano A, Garner AL, Stallings CL, Galburt EA. CarD stabilizes mycobacterial open complexes via a two-tiered kinetic mechanism. Nucleic Acids Res 2015; 43:3272–3285 [View Article] [PubMed]
    [Google Scholar]
  18. Hubin EA, Fay A, Xu C, Bean JM, Saecker RM et al. Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA. elife 2017; 6:e22520 [View Article] [PubMed]
    [Google Scholar]
  19. Haugen SP, Ross W, Gourse RL. Advances in bacterial promoter recognition and its control by factors that do not bind DNA. Nat Rev Microbiol 2008; 6:507–519 [View Article] [PubMed]
    [Google Scholar]
  20. Samaddar S, Grewal RK, Sinha S, Ghosh S, Roy S et al. Dynamics of mycobacteriophage-mycobacterial host interaction: evidence for secondary mechanisms for host lethality. Appl Environ Microbiol 2016; 82:124–133 [View Article] [PubMed]
    [Google Scholar]
  21. Azimi T, Mosadegh M, Nasiri MJ, Sabour S, Karimaei S et al. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review. Infect Drug Resist 2019; 12:2943–2959 [View Article] [PubMed]
    [Google Scholar]
  22. Ford ME, Sarkis GJ, Belanger AE, Hendrix RW, Hatfull GF. Genome structure of mycobacteriophage D29: implications for phage evolution. J Mol Biol 1998; 279:143–164 [View Article] [PubMed]
    [Google Scholar]
  23. Nagaraja V, Gopinathan KP. Transcriptional specificity after mycobacteriophage I3 infection. J Biosci 1987; 11:167–179 [View Article]
    [Google Scholar]
  24. Nechaev S, Severinov K. Bacteriophage-induced modifications of host RNA polymerase. Annu Rev Microbiol 2003; 57:301–322 [View Article] [PubMed]
    [Google Scholar]
  25. Jain S, Kaushal D, DasGupta SK, Tyagi AK. Construction of shuttle vectors for genetic manipulation and molecular analysis of mycobacteria. Gene 1997; 190:37–44 [View Article] [PubMed]
    [Google Scholar]
  26. Benito A, Feliu JX, Villaverde A. Beta-galactosidase enzymatic activity as a molecular probe to detect specific antibodies. J Biol Chem 1996; 271:21251–21256 [View Article] [PubMed]
    [Google Scholar]
  27. Chaudhuri B, Sau S, Datta HJ, Mandal NC. Isolation, characterization, and mapping of temperature-sensitive mutations in the genes essential for lysogenic and lytic growth of the mycobacteriophage L1. Virology 1993; 194:166–172 [View Article] [PubMed]
    [Google Scholar]
  28. Mukhopadhyay J, Mekler V, Kortkhonjia E, Kapanidis AN, Ebright YW et al. Fluorescence resonance energy transfer (FRET) in analysis of transcription-complex structure and function. Methods Enzymol 2003; 371:144–159 [View Article] [PubMed]
    [Google Scholar]
  29. Murakami K, Kimura M, Owens JT, Meares CF, Ishihama A. Activates neu5ac by addition of a cmp group. Proc Natl Acad Sci 1997; 94:1709–1714 [View Article]
    [Google Scholar]
  30. Sengupta S, Prajapati RK, Mukhopadhyay J. Promoter escape with bacterial two-component σ factor suggests retention of σ region two in the elongation complex. J Biol Chem 2015; 290:28575–28583 [View Article] [PubMed]
    [Google Scholar]
  31. Patra MM, Ghosh P, Sengupta S, Das Gupta SK. DNA binding and gene regulatory functions of MSMEG_2295, a repressor encoded by the dinB2 operon of Mycobacterium smegmatis. Microbiology (Reading) 2021; 167:10 [View Article] [PubMed]
    [Google Scholar]
  32. Zhang D, Lu M, Wang H. Fluorescence anisotropy analysis for mapping aptamer-protein interaction at the single nucleotide level. J Am Chem Soc 2011; 133:9188–9191 [View Article] [PubMed]
    [Google Scholar]
  33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402–408 [View Article] [PubMed]
    [Google Scholar]
  34. Bhawsinghka N, Dutta A, Mukhopadhyay J, Das Gupta SK. A transcriptomic analysis of the mycobacteriophage D29 genome reveals the presence of novel stoperator-associated promoters in its right arm. Microbiology (Reading) 2018; 164:1168–1179 [View Article] [PubMed]
    [Google Scholar]
  35. Mukherjee R, Chatterji D. Stationary phase induced alterations in mycobacterial RNA polymerase assembly: A cue to its phenotypic resistance towards rifampicin. Biochem Biophys Res Commun 2008; 369:899–904 [View Article] [PubMed]
    [Google Scholar]
  36. Chowdhury RP, Gupta S, Chatterji D. Identification and characterization of the dps promoter of Mycobacterium smegmatis: promoter recognition by stress-specific extracytoplasmic function sigma factors sigmaH and sigmaF. J Bacteriol 2007; 189:8973–8981 [View Article] [PubMed]
    [Google Scholar]
  37. Manganelli R, Voskuil MI, Schoolnik GK, Dubnau E, Gomez M et al. Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression. Mol Microbiol 2002; 45:365–374 [View Article] [PubMed]
    [Google Scholar]
  38. Li Q, Zhou M, Fan X, Yan J, Li W et al. Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability. Sci Rep 2016; 6:28701 [View Article] [PubMed]
    [Google Scholar]
  39. Cámara B, Liu M, Reynolds J, Shadrin A, Liu B et al. T7 phage protein Gp2 inhibits the Escherichia coli RNA polymerase by antagonizing stable DNA strand separation near the transcription start site. Proc Natl Acad Sci U S A 2010; 107:2247–2252 [View Article] [PubMed]
    [Google Scholar]
  40. Adhya S, Gottesman M, De Crombrugghe B. Release of polarity in Escherichia coli by gene N of phage lambda: termination and antitermination of transcription. Proc Natl Acad Sci U S A 1974; 71:2534–2538 [View Article] [PubMed]
    [Google Scholar]
  41. Rappsilber J, Ryder U, Lamond AI, Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res 2002; 12:1231–1245 [View Article] [PubMed]
    [Google Scholar]
  42. Bondarenko PV, Chelius D, Shaler TA. Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem 2002; 74:4741–4749 [View Article] [PubMed]
    [Google Scholar]
  43. Zhang B, VerBerkmoes NC, Langston MA, Uberbacher E, Hettich RL et al. Detecting differential and correlated protein expression in label-free shotgun proteomics. J Proteome Res 2006; 5:2909–2918 [View Article] [PubMed]
    [Google Scholar]
  44. Herrera-Asmat O, Lubkowska L, Kashlev M, Bustamante CJ, Guerra DG et al. Production and characterization of a highly pure RNA polymerase holoenzyme from Mycobacterium tuberculosis. Protein Expr Purif 2017; 134:1–10 [View Article] [PubMed]
    [Google Scholar]
  45. Hümpel A, Gebhard S, Cook GM, Berney M. The SigF regulon in Mycobacterium smegmatis reveals roles in adaptation to stationary phase, heat, and oxidative stress. J Bacteriol 2010; 192:2491–2502 [View Article] [PubMed]
    [Google Scholar]
  46. Pendzich J, Maksymowicz-Mazur W, Mazurek U, Dworniczak S, Oklek K et al. Quantitative analysis of sigma genes expression in Mycobacterium tuberculosis cultures exposed to rifampicin and isoniazid. Wiad Lek 2004; 57:233–240 [PubMed]
    [Google Scholar]
  47. Provvedi R, Boldrin F, Falciani F, Palù G, Manganelli R. Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology (Reading) 2009; 155:1093–1102 [View Article] [PubMed]
    [Google Scholar]
  48. DeMaio J, Zhang Y, Ko C, Young DB, Bishai WR. A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 1996; 93:2790–2794 [View Article] [PubMed]
    [Google Scholar]
  49. Michele TM, Ko C, Bishai WR. Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors. Antimicrob Agents Chemother 1999; 43:218–225 [View Article] [PubMed]
    [Google Scholar]
  50. Sachdeva P, Misra R, Tyagi AK, Singh Y. The sigma factors of Mycobacterium tuberculosis: regulation of the regulators. FEBS J 2010; 277:605–626 [View Article] [PubMed]
    [Google Scholar]
  51. Williams EP, Lee JH, Bishai WR, Colantuoni C, Karakousis PC. Mycobacterium tuberculosis SigF regulates genes encoding cell wall-associated proteins and directly regulates the transcriptional regulatory gene phoY1. J Bacteriol 2007; 189:4234–4242 [View Article] [PubMed]
    [Google Scholar]
  52. Beaucher J, Rodrigue S, Jacques P-E, Smith I, Brzezinski R et al. Novel Mycobacterium tuberculosis anti-sigma factor antagonists control sigmaF activity by distinct mechanisms. Mol Microbiol 2002; 45:1527–1540 [View Article] [PubMed]
    [Google Scholar]
  53. Provvedi R, Kocíncová D, Donà V, Euphrasie D, Daffé M et al. SigF controls carotenoid pigment production and affects transformation efficiency and hydrogen peroxide sensitivity in Mycobacterium smegmatis. J Bacteriol 2008; 190:7859–7863 [View Article] [PubMed]
    [Google Scholar]
  54. Raman S, Song T, Puyang X, Bardarov S, Jacobs WR et al. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J Bacteriol 2001; 183:6119–6125 [View Article] [PubMed]
    [Google Scholar]
  55. Graham JE, Clark-Curtiss JE. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U S A 1999; 96:11554–11559 [View Article] [PubMed]
    [Google Scholar]
  56. Stallings CL, Stephanou NC, Chu L, Hochschild A, Nickels BE et al. CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence. Cell 2009; 138:146–159 [View Article] [PubMed]
    [Google Scholar]
  57. Forti F, Mauri V, Dehò G, Ghisotti D. Isolation of conditional expression mutants in Mycobacterium tuberculosis by transposon mutagenesis. Tuberculosis (Edinb) 2011; 91:569–578 [View Article] [PubMed]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.001158
Loading
/content/journal/micro/10.1099/mic.0.001158
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error